Copyright
©The Author(s) 2016.
World J Gastroenterol. Sep 21, 2016; 22(35): 7857-7867
Published online Sep 21, 2016. doi: 10.3748/wjg.v22.i35.7857
Published online Sep 21, 2016. doi: 10.3748/wjg.v22.i35.7857
F≥2 (66%) | F = 4 (23%) | EV (10%) | ||||
L-TE | S-TE | L-TE | S-TE | L-TE | S-TE | |
Cut-off (kPa) | 8 | 36 | 12 | 46 | 19 | 65 |
Sensitivity | 83 (54-76) | 76 (61-81) | 92 (80-100) | 89 (72-99) | 73 (59-93) | 91 (81-100) |
Specificity | 65 (76-98) | 80 (65-93) | 80 (72-89) | 78 (82-96) | 47 (34-68) | 80 (65-94) |
LR+ | 2.4 | 3.9 | 4.6 | 4.5 | 1.4 | 4.5 |
LR- | 0.2 | 0.3 | 0.09 | 0.1 | 0.5 | 0.1 |
AUROC | 0.85 (0.78-0.92) | 0.80 (0.65-0.85) | 0.93 (0.88-0.96) | 0.84 (0.76-0.93) | 0.62 (0.41-0.89) | 0.90 (0.79-100) |
Ref. | Technique | Cut-off | Patients | Sens | Spec | LR+ | LR- | PPV | NPV | AUROC |
Chen et al[29], 2012 (prospective) | ARFI | 3.32 | 163 | 80.0 | 88.4 | 6.9 | 0.23 | 55.5 | 96.0 | 0.93 (0.89-0.97) |
Fraquelli et al[20], 2013 (prospective) | TE | 46.00 | 110 | 89.0 | 78.0 | 4.5 | 0.10 | 54.7 | 95.0 | 0.84 (0.76-0.92) |
Cabassa et al[30], 2015 (prospective) | ARFI | 3.05 | 51 | 73.0 | 84.0 | 4.5 | 0.32 | 91.0 | 77.0 | 0.80 (0.68-0.93) |
Bota et al[28], 2010 (prospective) | ARFI | 2.51 | 67 | 85.2 | 91.7 | 10.2 | 0.16 | 73.3 | 87.1 | 0.910 |
Grgurevic et al[39], 2015 (prospective) | RT-2D SWE | 24.00 | 66 | 66.7 | 86.7 | 5.01 | 0.38 | 75.0 | 81.3 | 0.821 |
Ref. | Technique | Cut-off | n | Prevalence | Sens | Spec | LR+ | LR- | PPV | NPV | AUROC |
Stefanescu et al[75], 2011 (prospective) | TE | 46.4 | 174 | 85% | 83.5 | 71.0 | 2.90 | 0.23 | 93.8 | 45.5 | 0.780 |
Hirooka et al[74], 2011 (prospective) | RT-SWE | 8.24 | 60 | 43% | 96.0 | 85.0 | 6.40 | 0.04 | 83.0 | 97.0 | 0.91 (0.873-0.99) |
Bota et al[85], 2012 (prospective) | ARFI | 2.55 | 140 | 43% | 96.7 | 21.0 | 18.00 | 0.15 | 47.6 | 89.4 | 0.578 |
Colecchia et al[64], 2012 (prospective) | TE | 55.00 | 100 | 53% | 71.7 | 96.0 | 17.00 | 0.29 | 95.3 | 75.2 | 0.941 (0.90-0.98) |
Vermehren et al[86], 2012 (prospective) | ARFI | 4.13 | 166 | 36% | 35.0 | 83.0 | 2.06 | 0.78 | 54.0 | 69.0 | 0.58 (0.49-0.67) |
Calvaruso et al[21], 2013 (prospective) | TE | 50.00 | 96 | 56% | 65.0 | 61.0 | 1.70 | 0.60 | 69.0 | 57.0 | 0.701 |
Fraquelli et al[20], 2013 (prospective) | TE | 48.00 | 26 | 42% | 100.0 | 60.0 | 2.50 | 0.01 | 33.5 | 98.7 | 0.90 (0.79-1.00) |
Sharma et al[76], 2013 (prospective) | TE | 40.80 | 200 | 71% | 94.0 | 76.0 | 3.90 | 0.08 | 91.0 | 84.0 | 0.89 (0.84-0.95) |
Takuma et al[87], 2013 (prospective) | ARFI | 3.18 | 340 | 38.8% | 98.5 | 60.1 | 2.46 | 0.02 | 61.0 | 98.4 | 0.93 (0.90-0.96) |
Takuma et al[88], 2016 (prospective) | ARFI | 3.36 | 60 | 40% | 95.4 | 77.8 | 4.31 | 0.05 | 74.2 | 96.6 | 0.93 (0.84-0.98) |
- Citation: Giunta M, Conte D, Fraquelli M. Role of spleen elastography in patients with chronic liver diseases. World J Gastroenterol 2016; 22(35): 7857-7867
- URL: https://www.wjgnet.com/1007-9327/full/v22/i35/7857.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i35.7857